i-phone i-arrow-right i-arrow-left i-chat i-email i-find-clinic i-safe i-gentle i-fast i-effective i-discreet i-search i-chevron-right i-chevron-right i-facebook i-twitter i-linkedin
Your next steps
1
Choose your preferred clinic location
2
All first appointments are charged at £995, except for Harley Street clinics, where first appointments are charged at £1,250. Should treatment NOT be required you will be charged £250 for consultation only.
3
Choose your preferred consultant
4
Choose your preferred time slot

Meet the eXroid Team

Your treatment and care is delivered by one of our GMC registered Consultant grade Specialist Doctors, the majority of which are Colorectal Surgeons or General Surgeons with a Specialist interest in colorectal treatment. The eXroid team of clinicians are backed and supported by a management team who have a wealth of experience in hospital and healthcare management, both in the NHS and private healthcare.

 

Our Doctors

abhi-sharma

Abhi Sharma

General Surgeon

Read More

Abhi Sharma

General Surgeon

Profile: Abhi Sharma completed his medical training in BJ Medical College and David Sassoon Hospital, Pune, India followed by three year general surgical residency training in SMS College and Hospital, Jaipur, India.

He moved to Yorkshire in 2001 and underwent basic surgical training (2001-2003) in Hull and East Yorkshire Hospitals NHS Trust. He then undertook basic sciences and clinical research under Professor John Monson and Professor Lesley Walker culminating in an MD in 2005. He started specialist registrar training in the Yorkshire Deanery in 2005.

He trained in Leeds, Hull and Sheffield among other hospitals in Yorkshire. He also went for a three month pelvic floor and proctology fellowship to Mannheim, Germany and worked with Professor Alex Herold.

After obtaining CCT   and completing specialist registrar training in June 2011, he went to Rochester, NY, USA for a colorectal fellowship to further his experience in colorectal surgery.

He started working in UHSM in July 2012.

His interests include pelvic floor surgery, laparoscopic and minimally invasive colorectal surgery including surgery for cancer and inflammatory bowel disease and advanced endoscopy and transanal microsurgical techniques. He has also been extensively involved in research during his career and has over 45 peer reviewed journal publications.​ He is closely involved with eXroid and has performed around 100 exroid treatments with excellent feedback from patients.

 

 

amit-sinha

Amit Sinha

General Surgeon

Read More

Amit Sinha

General Surgeon

I am very much interested in the appropriate management of haemorrhoids (piles) and other conditions of the back passage.  The symptoms from problems of the back passage, can often be a source of significant distress in people’s day to day lives.  This is also an area of clinical practice that is poorly understood and poorly managed by clinicians in general, making the situation worse for patients.

I have been involved with electrotherapy for treating haemorrhoidal symptoms for some time now and have seen the difference the treatment makes to patient’s symptoms first-hand.  For suitable patients, this is an effective treatment with very little disruption to working lives, and I continue to devote a part of my time to use this technique to help people with their chronic haemorrhoidal symptoms.

ayo-oshowo

Ayo Oshowo

Colorectal Surgeon

Read More

Ayo Oshowo

Colorectal Surgeon

Mr Ayo Oshowo is a Consultant Laparoscopic and Colorectal Surgeon at The Whittington Health NHS Trust. He is also a Hon Senior Lecturer at the University College London Medical School. He was first appointed in 2002.

He has a broad background in General Surgery and wide Specialist experience in endoscopy, laparoscopic surgery and colorectal diseases.

He has been the Cancer MDT Lead, Royal College Tutor in Surgery and head, department of surgery. He presently champions the Enhanced Recovery Programme, which offers excellent patients’ experience and good outcomes following surgery.

chris-macklin

Chris Macklin

Colorectal Surgeon

david-mcarthur

David McArthur

Colorectal Surgeon

james-pitt

James Pitt

Colorectal Surgeon

Read More

James Pitt

Colorectal Surgeon

Mr James Pitt trained as a doctor at the London Hospital Medical College, London University and qualified in 1989. His surgical training was in London at Charing Cross, Hammersmith and St Mary’s Hospitals. He became a Fellow of the Royal College of Surgeons of England (FRCS) in 1995. He carried out research into anal fissure treatments at University College London in 1996 and was awarded the degree of MSc with distinction in Surgical Science. In 2001 he was appointed as Consultant General Surgeon at the Ipswich Hospital, Suffolk and also had admitting rights at the Nuffield hospital, Ipswich and the Oaks Hospital, Colchester. He is now the senior General Surgeon at Ipswich Hospital. His practice is mainly colorectal surgery in particular laparoscopic bowel cancer surgery, management of perianal conditions and hernias.

paul-mackey

Paul Mackey

Colorectal Surgeon

Read More

Paul Mackey

Colorectal Surgeon

I qualified from Southampton Medical School in 1992 and undertook a variety of junior surgical training post in Wales, the South West and Queensland, Australia.  I then went on to obtain an MD thesis looking at anal sphincter damage and faecal incontinence following childbirth.  My higher surgical training was undertaken in Wales and, on completion, I completed a Colorectal Fellowship in St George Hospital, Sydney, Australia.  I completed my surgical training in 2006.

I offer laparoscopic colorectal surgery for both benign and malignant conditions affecting the colon, rectum and anus.  I also thoroughly enjoy training advanced surgical techniques to trainees.  As well as colorectal cancer, my main interest is in the treatment of benign anorectal conditions, including offering a variety of treatments for haemorrhoids.  I believe it is important to tailor the treatment to the individual patient and the type of haemorrhoids present.  I first treated haemorrhoids using Exroid in 2013 and have been very impressed with the patient reported outcomes following treatment.  I aim to publish more research into the long-term outcomes following Exroid treatment to further support its use as a first-line treatme

rajeev-kushwaha

Rajeev Kushwaha

Colorectal Surgeon

rosa-santa-cruz

Rosa Santa-Cruz

General Surgeon

Our Management Team

mark-hudson-peacock

Dr Mark Hudson-Peacock

Clinical Chairman and Medical Director

Read More

Dr Mark Hudson-Peacock

Clinical Chairman and Medical Director

Dr. Mark served as Managing Director until April 2018 and continues to serve as Medical Director on a part-time basis. Mark continues to carry out electrotherapy treatments and the training and accreditation of eXroid qualified doctors.

Mark qualified in medicine in 1987 and subsequently trained in Wales and Newcastle-upon-Tyne. He has been a Consultant Dermatologist and Dermatological Surgeon since 1996 and has run a successful private clinic, The Canterbury Skin and Laser Clinic Ltd, voted the top cosmetic clinic in Kent in both 2016 and 2018.

Mark started treating haemorrhoids using eXroid in 2014 and was convinced of the potential for it to be widely adopted, when he resigned his NHS post to help bring eXroid to the UK. He has carried out in excess of 1000 electrotherapy treatments for eXroid and believes that all patients with internal haemorrhoid disease should be given the opportunity to consider eXroid as a treatment choice.

graham-bason-3

Graham Bason

Founder and Commercial Executive Director

Read More

Graham Bason

Founder and Commercial Executive Director

A seasoned entrepreneur, Graham has a highly successful track record in sales,marketing and startups. Heading up a variety of companies within the home improvement sector.
As a long-term sufferer of haemorrhoids, Graham underwent a number of traditional treatments including banding which all proved to be unsuccessful. After many years of suffering and having virtually given up hope, it was whilst sitting around a swimming pool in Thailand, Graham first heard about this new treatment for haemorrhoids from the USA called electrotherapy. The discovery was a blue touch paper moment for Graham when he realised this technology was not available anywhere in the UK or any other nearby countries.
After successfully undergoing the electrotherapy treatment, Graham was determined that the treatment should be made available in the UK in order to help the millions of sufferers. He carefully handpicked a professional team of people he needed to help him bring the electrotherapy treatment into the UK. With the team in place he invested his own time and money and eXroid was born.

michael-wilshaw-2

Michael Wilshaw

Managing Director

Read More

Michael Wilshaw

Managing Director

Michael was appointed in April 2018. He brings extensive experience to eXroid, from both the public and private sectors. Michael has over 20 years’ experience in the NHS and Department of Health and was appointed to work with the Prime Minister’s Decision Unit (PMDU) on the design and implementation of healthcare policy in the UK. Since 2006, he has worked internationally in business and healthcare consulting, as well as in the UK private sector, whilst also retaining senior roles that support the NHS in increasing quality and performance. Michael is responsible for eXroid’s growth in the UK and expansion into continental Europe, as well as other carefully selected markets.

lisa-ellerker

Lisa Ellerker

Finance and Commercial Director

Read More

Lisa Ellerker

Finance and Commercial Director

Lisa joined eXroid in July 2018, following 20 years of commercial accounting experience across a wide spectrum of organisations – from asset management to European rail travel. She has extensive experience across all aspects of finance and accounting – financial, management, budgeting/forecasting, systems and process implementation, however has a main interest in financial analysis and appraisal for business strategy, growth and cost efficiency. Lisa also brings with her some very relevant experience from the healthcare sector following a position as NHS Finance Manager, which will be instrumental to eXroid’s growth.

kay

Kay Friend

RA/QA Manager

Read More

Kay Friend

RA/QA Manager

Kay was appointed in October 2019 as our RA/QA Manager. She has more than 32 years’ experience in Medical Devices Industry. Working previously as Regulatory Affairs Specialist for a global Medical device company she has sound knowledge in Regulatory Compliance and Quality Systems including ISO 13485. She is responsible for the manufacture of eXroid’s equipment, sterile consumable treatment kits and compliance with the regulatory requirements relating to them.

hannah-brinning

Hannah Brinning

Operations Manager

Read More

Hannah Brinning

Operations Manager

Hannah joined eXroid in June 2018, her significant career offers more than 20 years of experience leading service support operations. Having advanced through a number of specialised roles across all sectors, she has delivered a vast breadth of transformational projects and service improvements; successfully achieving several industry awards along the way.

Having managed several start-up ventures, she is bringing her knowledge to eXroid establishing solid foundations to ensure eXroid’s growth potential is maximised.

me

Matt Richardson

Marketing Manager

Read More

Matt Richardson

Marketing Manager

Matt Richardson joined in October 2019 to provide in-house marketing resource which is shared with Wren Healthcare. Matt’s experience is primarily digital marketing, focusing on website content and design, SEO, social media, and email marketing. Before joining eXroid, Matt has 7 years’ experience working in the medical device industry engaging with various stakeholders, clinicians & KOL’s within the NHS on behalf of a global medical device company.

 

Matt is currently a Director of Wren Healthcare, our trusted partners who provide our home electrotherapy treatment service.

charles1

Charles Gloor

Non Executive Director

Read More

Charles Gloor

Non Executive Director

With over 25 years experience, Charles has successfully started-up and led multinational subsidiaries and divisions of leading multinational pharmaceutical wholesalers, distributors, and retailers in Western & Eastern Europe as well as South East Asia.

 

He has been a non-executive director for companies Europe and Asia and was until recently a Trustee at the British Pharmacological Society and a Member of the Board of Directors of BPS Assessment.  He currently provides interim management and consulting services to pharmaceutical companies, wholesalers, distributors & 3PL’s, pharmacy franchise groups, as well investors in these sectors.

The safe, effective ​​treatment for piles

Non-invasive. Each treatment takes 10 – 30 minutes.

Walk-in walk-out with no anaesthesia.

Find Out More

Speak to one of our experienced advisors. All enquiries are handled with complete discretion.

eXroid COVID-19 Update

Elective treatments suspended for the next 3 weeks
Following the Prime Minister’s national address at 20:30 on Monday 23rd March, it is imperative that we do our utmost to restrict the spread of COVID-19 and safeguard our patients and their communities, our staff and our clinics. Whilst we will always aim to do all we can to help and bring relief to our patients, we are bound by the greater cause to limit this highly infectious virus. We are therefore, as of now, re-scheduling all of our clinics and appointments to over 3 weeks into the future in line with the government guidance.

We sincerely apologise for any inconvenience and we will speak to everyone of our booked patients individually and do all we can to provide support.

We do, however, understand that there are some extreme cases and where patients feel there is an extreme detriment to their quality of life and / or they are suffering excessive bleeding, we will continue to provide our service on an emergency basis, where possible. This will be preceded by a triage call with myself initially, to ascertain what the issues are and to try to help remotely with a prescription, if possible, in the short term. If you have any concerns please contact us on 0800 999 3777.

We will continue to keep all of our patients directly informed and fully intend to treat everyone as planned, once the current restrictions have been lifted, presently scheduled for after the next three weeks.

The latest information is available at: https://www.gov.uk/government/publications/covid-19-stay-at-home-guidance

Again, if there are any questions or support we can offer, our team will remain working and available to support.

Kind Regards,

Dr Mark J. Hudson-Peacock,
Chairman and Medical Director